Evogene has been granted a patent for isolated polynucleotides encoding insecticidal polypeptides, used to kill or inhibit insect pests and confer resistance to plants. The patent also covers compositions with pesticidal proteins and host cells expressing these proteins, particularly bacterial cells. GlobalData’s report on Evogene gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Evogene Ltd - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Evogene, was a key innovation area identified from patents. Evogene's grant share as of February 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.

Genetically modified bacterial strain for insect pest control

Source: United States Patent and Trademark Office (USPTO). Credit: Evogene Ltd

A recently granted patent (Publication Number: US11859197B2) discloses a genetically modified bacterial strain capable of expressing specific polypeptides that can kill or inhibit the development of insect pests. The patent claims include the use of bacterial lysate, nucleic acid constructs encoding the insecticidal polypeptides, compositions comprising these constructs, and isolated cells transformed with them. The patent also covers methods for increasing plant resistance to insect pests by either transforming plants with the nucleic acid constructs or by directly contacting plants with the genetically modified bacterial strain or its composition.

Furthermore, the patent extends to the transformation of various types of cells, including bacterial, plant, yeast, and insect cells, with the nucleic acid constructs encoding the insecticidal polypeptides. It also includes the transformation of plants with these constructs to confer resistance to insect pests. The methods outlined in the patent offer alternative approaches to enhancing plant resistance to insect pests, either through genetic modification of the plant itself or through the application of the genetically modified bacterial strain or its components. This patent represents a significant development in the field of agricultural biotechnology, providing novel solutions for pest management in crops.

To know more about GlobalData’s detailed insights on Evogene, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies